Two pathogenic point mutations exist in the authentic mitochondrial genome, not in the nuclear pseudogene

Area of Science:

• Molecular genetics
• Mitochondrial biology
• Genetics

Background:

• Mitochondrial myopathies are associated with various mitochondrial DNA (mtDNA) abnormalities.
• Nuclear DNA in affected patients can contain sequences resembling mtDNA (nuclear pseudogenes) with potentially pathogenic mutations.
• Distinguishing between authentic mtDNA mutations and nuclear pseudogenes is crucial for diagnosis.

Purpose of the Study:

• To verify the presence of specific point mutations (T3250C and T3291C) in the authentic mitochondrial genome of patients with mitochondrial myopathy.
• To establish a reliable method for differentiating between pathogenic mtDNA mutations and nuclear pseudogenes.

Main Methods:

• Utilized long polymerase chain reaction (PCR) to specifically amplify authentic mtDNA.
• Analyzed patient samples to detect T3250C and T3291C mutations within the mitochondrial genome.
• Employed PCR techniques to avoid amplification of nuclear pseudogene sequences.

Main Results:

• Confirmed the existence of T3250C and T3291C mutations within the authentic mitochondrial genome of patients.
• Demonstrated that long PCR effectively prevents amplification of nuclear pseudogenes.
• Showed that long PCR eliminates ambiguity in mutation detection for mitochondrial myopathy diagnosis.

Conclusions:

• The T3250C and T3291C mutations found in mitochondrial myopathy patients are located in the authentic mitochondrial genome.
• Long polymerase chain reaction is a highly effective method for accurate diagnosis of mitochondrial myopathies by avoiding nuclear pseudogene interference.
• This technique enhances diagnostic certainty for mitochondrial genetic disorders.